China Cabozantinib Manufacturers & Exporter

Cabozantinib (CAS No.: 849217-68-1 for free base; CAS No.: 1140909-48-3 for Cabozantinib S-malate) represents a cornerstone in small-molecule targeted oncology therapeutics. As a potent multi-kinase inhibitor targeting VEGFR-1, VEGFR-2, VEGFR-3, MET (Hepatocyte Growth Factor Receptor), AXL, RET, KIT, and FLT3, Cabozantinib plays an indispensable role in suppressing tumor angiogenesis, invasive metastasis, and drug-resistance pathways. For global pharmaceutical companies, generic drug developers, and contract development and manufacturing organizations (CDMOs), securing a reliable, cGMP-compliant, and scalable supply of Cabozantinib API and its key intermediates from leading Chinese manufacturers has become a critical strategic objective.

Chemical Profile & Synthesis Pathway Optimization

The chemical structure of Cabozantinib, chemically known as N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, demands rigorous stereocontrol, minimal impurity carryover, and high yield stability during industrial-scale synthesis. Key intermediates such as 4-chloro-6,7-dimethoxyquinoline and 4-aminophenol derivatives require meticulous quality control to prevent the formation of genotoxic impurities (GTIs).

Leading Chinese chemical manufacturers have revolutionized the synthetic route by deploying green chemistry methodologies, continuous flow micro-reactors, and optimized catalytic condensation procedures. This technical advancement ensures lower trace solvent residues, improved polymorphic form purity (Form N-1 and Form N-2 control), and consistency across multi-ton commercial batches.

Why Source Cabozantinib from China? Supply Chain Advantages

China has established itself as the world's most robust ecosystem for active pharmaceutical ingredient production and custom chemical synthesis. When evaluating Cabozantinib suppliers, international procurement directors benefit from several distinct structural advantages:

• Upstream Raw Material Integration: China produces over 80% of global basic chemical building blocks. The complete vertical integration from basic petrochemical starting materials to advanced Cabozantinib intermediates mitigates global supply disruption risks.
• Scale Economy & Cost Efficiency: Advanced manufacturing infrastructure combined with optimized process chemistry provides highly competitive pricing without sacrificing regulatory compliance or product quality.
• Strict Regulatory Oversight: Modern Chinese manufacturing plants operate under strict NMPA, US FDA, and WHO-cGMP guidelines, featuring automated environmental safety, EH&S compliance, and full traceability.